1. Home
  2. CARS vs IRWD Comparison

CARS vs IRWD Comparison

Compare CARS & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cars.com Inc.

CARS

Cars.com Inc.

HOLD

Current Price

$11.38

Market Cap

627.9M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$4.14

Market Cap

713.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CARS
IRWD
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
627.9M
713.8M
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
CARS
IRWD
Price
$11.38
$4.14
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$16.00
$7.67
AVG Volume (30 Days)
488.8K
1.6M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1400.00
EPS
0.33
0.55
Revenue
$723,239,000.00
$298,276,000.00
Revenue This Year
$3.03
$57.95
Revenue Next Year
$2.57
$4.39
P/E Ratio
$35.55
$7.75
Revenue Growth
0.57
8.88
52 Week Low
$7.40
$1.05
52 Week High
$13.85
$5.78

Technical Indicators

Market Signals
Indicator
CARS
IRWD
Relative Strength Index (RSI) 41.97 47.17
Support Level $10.65 $3.89
Resistance Level $11.61 $4.53
Average True Range (ATR) 0.41 0.18
MACD -0.09 -0.02
Stochastic Oscillator 6.82 22.11

Price Performance

Historical Comparison
CARS
IRWD

About CARS Cars.com Inc.

Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: